medetomidine has been researched along with endothelin-1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, T; Gardiner, SM; Kemp, PA; March, JE | 1 |
| Bowen, IM; Chester, AH; Elliott, J; Marr, CM; Wheeler-Jones, CP | 1 |
2 other study(ies) available for medetomidine and endothelin-1
| Article | Year |
|---|---|
Cardiovascular effects of endothelin-1 and endothelin antagonists in conscious, hypertensive ((mRen-2)27) rats.
Topics: Anesthetics; Animals; Animals, Genetically Modified; Baroreflex; Blood Pressure; Butyrophenones; Cardiovascular Agents; Consciousness; Dioxoles; Dose-Response Relationship, Drug; Drug Combinations; Endothelin Receptor Antagonists; Endothelin-1; Female; Fentanyl; Heart; Heart Rate; Humans; Hypertension; Indans; Male; Medetomidine; Methohexital; Mice; Midazolam; Pyrazoles; Rats; Rats, Sprague-Dawley; Renin; Time Factors | 2000 |
In-vitro contraction of the equine aortic valve.
Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Aortic Valve; Bridged Bicyclo Compounds, Heterocyclic; Dose-Response Relationship, Drug; Endothelin-1; Fatty Acids, Unsaturated; Free Radical Scavengers; Horses; Hydrazines; Medetomidine; Models, Animal; Models, Cardiovascular; Myocardial Contraction; Norepinephrine; Phenylephrine; Prostaglandin Endoperoxides, Synthetic; Receptors, Thromboxane; Serotonin; Statistics as Topic; Vasoconstrictor Agents | 2004 |